Christina Junvik, M.SC. has almost 20 years of experience in pharmaceutical drug development and provides services to pharma and biotech companies. Main therapeutic area is oncology, early translational phase with clinical focus. Services includes general development aspects such as preparing the project for financing or due dilligence, identify gaps in data packages, target product profile, or Scientific Advice support. Activites in clinical development includes e.g. strategy, study design, medical writing (Investigators Brochure, study protocol, briefing material, orphan drug applications).
https://www.linkedin.com/in/christinajunvik/
Company Details
- Employees
- 1
- Founded
- -
- Address
- Medeon Science Park, Per Albin Hanssons Väg 41,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.junvikconsulting.com
- Keywords
- Early drug development, Oncology, Medical Writing, Study design, Study protocol, Investigators Brochure, Small molecules and biologics, ATMP, Clinical, Regulatory, Team success, Happy teams.
- HQ
- MALMÖ
Junvik Consulting Questions
Junvik Consulting's website is http://www.junvikconsulting.com
Junvik Consulting's LinkedIn profile is https://se.linkedin.com/company/junvikconsulting
Junvik Consulting has
1 employees.
View email and phone details for 1
employees at Junvik Consulting.
Junvik Consulting's industry is
Biotechnology Research
Junvik Consulting's top competitors are
Morenco Pharma Ab,
Gain Pharmaceuticals,
Lithea Ab (Former Moroxite T Ab),
Meditrials,
Biotech-Igg,
Innate Pharmaceuticals Ab,
Rare Thyroid Therapeutics,
Implexion Pharma,
Eribis Pharmaceuticals,
Abarceo Pharma Ab.
Junvik Consulting's categories are Biotechnology Research
Junvik Consulting's founding year is 2021
